MUMBAI (Reuters) - Pfizer Inc may bid for Ranbaxy Laboratories Ltd, countering a $4.6 billion offer by Japan’s Daiichi Sankyo Co Ltd (Tokyo:4568.T - News) for the Indian generic drug maker, the Business Standard newspaper said.
MUMBAI (Reuters) - Pfizer Inc may bid for Ranbaxy Laboratories Ltd, countering a $4.6 billion offer by Japan’s Daiichi Sankyo Co Ltd (Tokyo:4568.T - News) for the Indian generic drug maker, the Business Standard newspaper said.
